March 6 (Reuters) - Pfizer (PFE.N), opens new tab on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of its closely ...

Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment is a new chief internal medicine officer. In the role, James List ...

Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine portfolio and will be responsible for advancing the ...

Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal medicine officer to boost the company's efforts in obesity drug ...

(Reuters) -Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of its closely watched oral weight-loss drug ...

Australians pay some of the lowest medicine prices in the world for a reason: our Pharmaceutical Benefits Scheme. Here’s how ...

Investors turned their attention to corporate news while awaiting the latest developments on Trump’s tariffs, which have ...

Once the team has narrowed the list, it evaluates a firm's competitive ... It’s a diverse group, including pharmaceutical giants Merck and Pfizer, along with pharmacy and benefits manager ...